Harvard Bioscience Stock Alpha and Beta Analysis
| HBIO Stock | USD 0.45 0.01 2.46% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Harvard Bioscience. It also helps investors analyze the systematic and unsystematic risks associated with investing in Harvard Bioscience over a specified time horizon. Remember, high Harvard Bioscience's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Harvard Bioscience's market risk premium analysis include:
Beta 2.19 | Alpha (0.37) | Risk 5.58 | Sharpe Ratio (0) | Expected Return (0.02) |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Check out Harvard Bioscience Backtesting, Harvard Bioscience Valuation, Harvard Bioscience Correlation, Harvard Bioscience Hype Analysis, Harvard Bioscience Volatility, Harvard Bioscience History and analyze Harvard Bioscience Performance. Harvard Bioscience Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Harvard Bioscience market risk premium is the additional return an investor will receive from holding Harvard Bioscience long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Harvard Bioscience. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Harvard Bioscience's performance over market.| α | -0.37 | β | 2.19 |
Harvard Bioscience expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Harvard Bioscience's Buy-and-hold return. Our buy-and-hold chart shows how Harvard Bioscience performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Harvard Bioscience Market Price Analysis
Market price analysis indicators help investors to evaluate how Harvard Bioscience stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Harvard Bioscience shares will generate the highest return on investment. By understating and applying Harvard Bioscience stock market price indicators, traders can identify Harvard Bioscience position entry and exit signals to maximize returns.
Harvard Bioscience Return and Market Media
The median price of Harvard Bioscience for the period between Thu, Jun 26, 2025 and Wed, Sep 24, 2025 is 0.48 with a coefficient of variation of 7.59. The daily time series for the period is distributed with a sample standard deviation of 0.04, arithmetic mean of 0.48, and mean deviation of 0.03. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Insider Trading | 07/16/2025 |
2 | Harvard Bioscience Schedules Second Quarter 2025 Earnings Conference Call for August 11, 2025 at 800 AM ET | 08/04/2025 |
3 | Acquisition by John Duke of 500000 shares of Harvard Bioscience subject to Rule 16b-3 | 08/08/2025 |
4 | Disposition of 113366 shares by James Green of Harvard Bioscience subject to Rule 16b-3 | 08/15/2025 |
5 | Tariffs and policy uncertainty weigh on U.S. economy economists | 08/22/2025 |
6 | What momentum shifts mean for Harvard Bioscience Inc. - Portfolio Update Summary AI Based Buy and Sell Signals - Newser | 08/25/2025 |
7 | Is this a good reentry point in Harvard Bioscience Inc. - July 2025 Update Accurate Intraday Trading Signals - Newser | 08/28/2025 |
8 | Is Harvard Bioscience Inc. building a consolidation base - July 2025 Rallies Target Return Focused Stock Picks - Newser | 09/05/2025 |
9 | Harvard Bioscience appoints DeNelsky to board of directors HBIO | 09/09/2025 |
10 | Harvard Bioscience Expands Distribution Agreement with Fisher Scientific to Include United States | 09/16/2025 |
About Harvard Bioscience Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Harvard or other stocks. Alpha measures the amount that position in Harvard Bioscience has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2024 | 2025 (projected) | Dividend Yield | 0.002551 | 0.002218 | Price To Sales Ratio | 0.98 | 1.69 |
Harvard Bioscience Upcoming Company Events
As portrayed in its financial statements, the presentation of Harvard Bioscience's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Harvard Bioscience's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Harvard Bioscience's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Harvard Bioscience. Please utilize our Beneish M Score to check the likelihood of Harvard Bioscience's management manipulating its earnings.
| 14th of March 2024 Upcoming Quarterly Report | View | |
| 23rd of April 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 14th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Harvard Bioscience
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Harvard Bioscience Backtesting, Harvard Bioscience Valuation, Harvard Bioscience Correlation, Harvard Bioscience Hype Analysis, Harvard Bioscience Volatility, Harvard Bioscience History and analyze Harvard Bioscience Performance. To learn how to invest in Harvard Stock, please use our How to Invest in Harvard Bioscience guide.You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Harvard Bioscience technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.